Co-Diagnostics, Inc. (CODX)

1,5900 -0,1000 (-5,92%) Al cierre: 04:00PM EDT

Co-Diagnostics, Inc.

2401 South Foothill Drive
Suite D
Salt Lake City, UT 84109
United States
(801) 438-1036
https://www.codiagnostics.com

Sector(es): Healthcare
Sector: Medical Devices
Empleados a tiempo completo: 155

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Dwight H. Egan	Chairman & CEO	415,75k	N/A	1953
Mr. Brian L. Brown CPA	CFO & Company Secretary	338,92k	N/A	1976
Mr. Richard David Abbott	President	N/A	N/A	1972
Dr. Brent C. Satterfield Ph.D.	Co-Founder & Member of Scientific Advisory Board	237,5k	N/A	1977
Mr. David Nielsen	Chief Operating Officer	N/A	N/A	N/A
Mr. Dan Bohrer CPA	Vice President of Finance & Accounting	N/A	N/A	N/A
Mr. Christopher Thurston	Chief Technology Officer	N/A	N/A	N/A
Mr. Andrew Benson	Head of Investor Relations	N/A	N/A	N/A
Dr. Mayuranki Almaula	Senior Vice President of Overseas Operations & Strategic Alliances	N/A	N/A	N/A
Mr. Cameron Gundry	Head of Commercialization LATAM/EUR	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Gobierno corporativo

El ISS Governance QualityScore de Co-Diagnostics, Inc., a día 1 de junio de 2024, es 9. Las puntuaciones base son Auditoría: 9; Tablero: 10; Derechos de los accionistas: 5; Compensación: 8.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.